Puerto Rico: Virtual Manufacturer and Virtual Distributor License Applications Now Open As of October 10th, 2024, the Puerto Rico Department of...

Automated Regulatory Updates with LighthouseAI  LighthouseAI is changing the way licensing professionals track and monitor new and changing laws and...

New NABP DDA (VAWD) Alternative Accreditation  We were recently informed by the National Board of Pharmacy about an alternative NABP Drug...

Puerto Rico Suspends Controlled Substance Applications The Puerto Rico Department of Health recently suspended controlled substance applications...

The FDA recently released a statement1 regarding the upcoming enforcement of section 582 of the FD&C act regarding trading partners. Section 582...

Semaglutide Article Series:  In a 2-part series, LighthouseAI will be diving into how the pharma and pharmacy industries are addressing the shortage...

Kentucky Revisiting Licensing of Non-Registered Pharmacist   Kentucky Board of Pharmacy posted in the May 1, 2024, Administrative Register (register...

The Current State of Xylazine   What is Xylazine?  A tranquilizer called xylazine has been increasingly found on the black market and associated...

Navigating Puerto Rico's New Licensing Standards for Pharmaceutical Wholesale Distributors   The Puerto Rico Department of Health has recently...

1856 Changes By Regulatory Agencies Since January 1st, 2024  Regulatory agencies have been very active since the start of the year writing new...

Connecticut Reporting Transparency Updates In 2018, Connecticut established the Office of Health Strategy (OHS) with a clear mission: to implement...

New Mexico Passes Prescription Drug Price Transparency Act New Bill: HB0033AFS (nmlegis.gov)  Effective: 01/01/2025 The new bill, titled the...